🔸(1-3)

✅AF FOCUSED UPDATE: 2014-2019 COMPARISON TOOL
Recommendations for Selecting an Anticoagulant Regimen—Balancing Risks and Benefits
2019 AHA/ACC/HRS Focused Update of the 2014 #Guideline for the Management of Patients with Atrial Fibrillation

✨ Join Us✨

📲 @IRathero💫

🔸(2-3)

✅AF FOCUSED UPDATE: 2014-2019 COMPARISON TOOL
Recommendations for Selecting an Anticoagulant Regimen—Balancing Risks and Benefits
2019 AHA/ACC/HRS Focused Update of the 2014 #Guideline for the Management of Patients with Atrial Fibrillation

✨ Join Us✨

📲 @IRathero💫

🔸(3-3)

✅AF FOCUSED UPDATE: 2014-2019 COMPARISON TOOL
Recommendations for Selecting an Anticoagulant Regimen—Balancing Risks and Benefits
2019 AHA/ACC/HRS Focused Update of the 2014 #Guideline for the Management of Patients with Atrial Fibrillation

✨ Join Us✨

📲 @IRathero💫

🔸(1-2)

✅ AF FOCUSED UPDATE: 2014-2019 COMPARISON TOOL
Recommendations for Prevention of Thromboembolism
2019 AHA/ACC/HRS Focused Update of the 2014 #Guideline for the Management of Patients with Atrial Fibrillation

✨ Join Us✨

📲 @IRathero💫

🔸(2-2)

✅ AF FOCUSED UPDATE: 2014-2019 COMPARISON TOOL
Recommendations for Prevention of Thromboembolism
2019 AHA/ACC/HRS Focused Update of the 2014 #Guideline for the Management of Patients with Atrial Fibrillation

✨ Join Us✨

📲 @IRathero💫

🔸 (1-3)
Top 10 Take-Home Messages for the Primary Prevention of #Cardiovascular Disease 2019 #Guideline

💻 https://bit.ly/2xBdWYA

✨ Join Us✨👇

📲 @IRathero 💫

🔸 (2-3)
Top 10 Take-Home Messages for the Primary Prevention of #Cardiovascular Disease 2019 #Guideline

💻 https://bit.ly/2xBdWYA

✨ Join Us✨👇

📲 @IRathero 💫

🔸 (3-3)
Top 10 Take-Home Messages for the Primary Prevention of #Cardiovascular Disease 2019 #Guideline

💻 https://bit.ly/2xBdWYA

✨ Join Us✨👇

📲 @IRathero 💫

🔸 (1-3)
Top 10 Take-Home Messages for the Primary Prevention of #Cardiovascular Disease 2019 #Guideline

💻 https://bit.ly/2xBdWYA

✨ Join Us✨👇

📲 @IRathero 💫

🔸 (2-3)
Top 10 Take-Home Messages for the Primary Prevention of #Cardiovascular Disease 2019 #Guideline

💻 https://bit.ly/2xBdWYA

✨ Join Us✨👇

📲 @IRathero 💫

🔸 (3-3)
Top 10 Take-Home Messages for the Primary Prevention of #Cardiovascular Disease 2019 #Guideline

💻 https://bit.ly/2xBdWYA

✨ Join Us✨👇

📲 @IRathero 💫

🌎🌎🌎
📚 به روز رسانی #اطلاعات 📕📖

✅ Aspirin Recommendations- 2019 ACC/AHA #Guideline on the Primary Prevention of Cardiovascular Disease

According to 2019 ACC/AHA #Guideline on the Primary Prevention of Cardiovascular Disease:

•Aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit.

•Low-dose aspirin should not be given on a routine basis for the purpose of preventing heart attacks and other heart disease in people aged 70 years and older or adults of any age who are at increased risk of bleeding.

•These guidelines apply to people who have not been previously diagnosed with heart disease

•It is also recommended that adults who are 40 to 75 years of age and are being evaluated for cardiovascular disease prevention should undergo 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation and have a clinician–patient risk discussion before starting on pharmacological therapy, such as antihypertensive therapy, a statin, or aspirin. In addition, assessing for other risk-enhancing factors can help guide decisions about preventive interventions in select individuals, as can coronary artery calcium scanning

🖥 https://bit.ly/2m8aaTQ

✨ Join Us✨👇

📲 @IRathero 💫

🔸 (1-3)
Top 10 Take-Home Messages for the Primary Prevention of #Cardiovascular Disease 2019 #Guideline

💻 https://bit.ly/2xBdWYA

✨ Join Us✨👇

📲 @IRathero 💫

🔸 (2-3)
Top 10 Take-Home Messages for the Primary Prevention of #Cardiovascular Disease 2019 #Guideline

💻 https://bit.ly/2xBdWYA

✨ Join Us✨👇

📲 @IRathero 💫

🔸 (3-3)
Top 10 Take-Home Messages for the Primary Prevention of #Cardiovascular Disease 2019 #Guideline

💻 https://bit.ly/2xBdWYA

✨ Join Us✨👇

📲 @IRathero 💫

✅ #برنامه_علمی #وبینار اصول نوین #فشار_خون شریانی و آخرین دستورالعمل ها

✅ Essential Updates on Hypertension from #Guideline to Office

🗓پنجشنبه : 5 تیرماه 1399
🕰ساعت : 14:00 الي 15:30

📌جهت حضور در #وبينار به لينك زير مراجعه نماييد.👇

🖥 https://webinar.actoverco.com/ch/updates-on-hypertension

🖥 http://fa.iranathero.ir/

🖥 http://iranathero.ir/


✨ Join Us✨

📲 http://tttttt.me/Irathero 💫

✅ #برنامه_علمی #وبینار اصول نوین #فشار_خون شریانی و آخرین دستورالعمل ها

✅ Essential Updates on Hypertension from #Guideline to Office

🗓پنجشنبه : 5 تیرماه 1399
🕰ساعت : 14:00 الي 15:30

📌جهت حضور در #وبينار به لينك زير مراجعه نماييد.👇

🖥 https://webinar.actoverco.com/ch/updates-on-hypertension

🖥 http://fa.iranathero.ir/

🖥 http://iranathero.ir/


✨ Join Us✨

📲 http://tttttt.me/Irathero 💫

✅ #برنامه_علمی #وبینار اصول نوین #فشار_خون شریانی و آخرین دستورالعمل ها

✅ Essential Updates on Hypertension from #Guideline to Office

🗓پنجشنبه : 5 تیرماه 1399
🕰ساعت : 14:00 الي 15:30

📌جهت حضور در #وبينار به لينك زير مراجعه نماييد.👇

🖥 https://webinar.actoverco.com/ch/updates-on-hypertension

🖥 http://fa.iranathero.ir/

🖥 http://iranathero.ir/


✨ Join Us✨

📲 http://tttttt.me/Irathero 💫

❣️📚📚📚📚📚❣️

🗒به روز رسانی #اطلاعات

✅ 2020 #ACC/AHA_Guidelines ❤️

❣️2020 ACC/AHA #Guideline for the Management of Patients With Valvular Heart Disease ❣️


💌 #دانلود کامل #گایدلاین👇👇👇

💻 air.ir/ZHmRQ

💻 air.ir/ZHmSQ


✨ Join Us✨

📲 @IRathero 💫

‍ ❣️📚📚📚📚📚❣️

🗒به روز رسانی #اطلاعات

✅ 2020 #ACC/AHA_Guidelines ❤️

❣️2020 ACC/AHA #Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy ❣️


💌 #دانلود کامل #گایدلاین👇👇👇

💻 air.ir/ZHm8R

💻 air.ir/ZHm7R


✨ Join Us✨

📲 @IRathero 💫